What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models)

What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models)

In prostate cancer (PC), the PD-1/PD-L1 axis regulates various signaling pathways and it is influenced by extracellular factors. Pre-clinical experimental studies investigating the effects of various treatments (alone or combined) may discover how to overcome the immunotherapy-resistance in PC-patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea Palicelli, Stefania Croci, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Moira Ragazzi, Magda Zanelli, Alcides Chaux, Sofia Cañete-Portillo, Maria Paola Bonasoni, Alessandra Soriano, Stefano Ascani, Maurizio Zizzo, Carolina Castro Ruiz, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Daniel M. Berney, Jatin Gandhi, Giacomo Santandrea, Martina Bonacini
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
PD-L1
prostate
cancer
signaling pathways
microenvironment
target-therapy
Biology (General)
QH301-705.5
Chemistry
QD1-999
Online Access:https://doaj.org/article/24141efcf236458cb9f0961939c8a0bd
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/24141efcf236458cb9f0961939c8a0bd

Similar Items